Company News from 12/09/05 News Brief
Bristol-Myers Squibb announced a collaboration agreement with biotech company Exelixis to discover, develop and commercialize novel therapies targeted against the ...
Your Email Address: *
Recipient(s) Email Address: *
(Separate multiple e-mail addresses with commas. Limited to 20 addresses.)
The e-mail address(es) that you supply to use this service will only be used to send the requested article.